About Us


Our Mission is to stop cancer before it starts and to help you and your loved ones avoid cancer.

Our Philosophy is to provide a simple, convenient, accurate, economic and effective tool to make cancer prevention and interception transparent, actionable and measurable.

Our Foundation is the Art of War.

Our Silver Bullet is the iCRM, intelligent Cancer Risk Monitor, equipped with 13 unique cancer risk predictive algorithms and AI simulation techniques.




Cancer has a major impact on society in the United States and across the world. There will be an estimated 1,688,780 new cancer cases and 600,920 cancer deaths in 2017 in the U.S. The WHO warns that cancer cases could explode in the next 20 years. That’s a problem that Charles is on a mission to solve. At age 21, Charles co-founded a health tech startup, AI Health (American Intelligent Health Technologies), creating an intelligent cancer risk monitor that helps people stop cancer from forming. Charles started his research career at age 16 when he presented his first cross-culture research study at Cambridge University of UK in July 2012. During his first two years of college, Charles worked with research scientists and medical professors on four cancer research studies that were presented at the 40th ESMO European Cancer Congress and the 2016 UICC World Cancer Congress. Charles is also the co-inventor of three pending patents with machine learning algorithms helping people avoid cancer & stroke.

Charles recently graduated from the University of Washington with a major in Applied and Computational Mathematical Sciences (ACMS). Outside numbers and algorithms, Charles enjoys shooting archery and was one of the top archers in the United States Intercollegiate Archery Championships.

The Crew


Qiu ping 

Co-founder, chief technology officer

Prior to AIH, Qiu Ping was Lead Software Engineer of  the Business Intelligence Group at IBM (2006-2017). Before joining IBM, he was Sr. Software Engineer at FileNet. Qiu Ping received a Master’s Degree in Computer Science and a Master’s Degree in Biomechanics from Indiana University.

George Wu

Managing Director

Prior to AIH, George Wu was COO at Yingli Tech. George has been managing medical research and healthcare analytics projects for over 20 years. George holds a BA in Biology from Wannan Medical College and a MD from Indiana University School of Medicine.

Will Tao

Chief Medical Director

Will is a Professor of Oncology of Bengbu Medical University. Prior to AIH, Will was SVP of Wanbei Hospital. Will’s research focuses on surgical treatment of breast cancer and early detection of breast cancer. He is a member of the National
Cancer Society and a committee member of the Anhui Province Cancer Society since 2002. Will received numerous awards in the
last 20 years in recognition of his research contributions in the field of surgical treatment of breast cancer.

Young Gee

Medical Research Advisor

Young is a Professor of Medicine at Anhui Medical University. Prior to AIH, Young was the Chief of the Division of Oncology of Fuyang City Hospital. His research has focused on thoracic surgery and he has been a member of the National Association for Thoracic Surgery since 1989. He received the National Award in 2004 in recognition of his research contributions in the field of surgical treatment of lung cancer.

Shelly Wang

Head of people

Prior to AIH, Shelly was Head of People at Yingli Tech. Shelly holds a Bachelor’s Degree from
Beijing Union University and a Master’s Degree in Psychology from Texas Christian University.

Young Young Ma

Volunteer Program Lead

Young Young is a senior student of Skyline High School. Young Young has been involved in the Awareness and Education program to help raise awareness about cancer and educate others about cancer prevention and interception. He is leading the Fundraising program.

Know your enemy, know yourself. A thousand battles, a thousand victories. ~ Sun Tzu